Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective Corrigendum to Commission Implementing Decision 2012/411/EU of 17 July 2012 amending Decision 2010/472/EU as regards animal health requirements relating to Simbu viruses and epizootic haemorrhagic disease ( Official Journal of the European Union L 192 of 20 July 2012 )

Rozhodnutie č. 411/2012

Text language

Important dates

Declared: 1. decembra 2012
Approved: 1. decembra 2012

Documents and links

Corrigendum to Commission Implementing Decision 2012/411/EU of 17 July 2012 amending Decision 2010/472/EU as regards animal health requirements relating to Simbu viruses and epizootic haemorrhagic disease

On page 27, in the Annex, point (4), ‘Model health certificate for imports of consignments of ova and embryos of animals of the ovine and caprine species’:

for:

Image 1

‘(1)(5) or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were subjected with negative results in each case to:

(1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of ova/embryos (1);]

(1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of ova/embryos (1);]

(1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of ova/embryos (1);]]

(1) either [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]

(1) or [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and are destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in that point and with the guarantees (7) requested by the Member State of destination;]

II.2.9. were collected/produced (1) after the date on which the embryo collection team was approved by the competent authority of the exporting country;

II.2.10. were processed and stored under approved conditions for at least 30 days immediately after their collection/production (1) and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.11. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in Box I.23;

(9) II.2.12. were conceived by artificial insemination/as a result of in vitro fertilisation (1) using semen coming from semen collection centres.

(1) either [II.2.12.1. approved in accordance with Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]

(1) or [II.2.12.1. approved in accordance with Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]’

read:

Image 2

‘(1)(5) or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and the donors were subjected with negative results in each case to:

(1) either [on two occasions not more than 12 months apart in a serological test (6) carried out in an approved laboratory on samples of blood taken prior to and not less than 21 days following collection for this consignment of ova/embryos (1);]

(1) or [a serological test (6) for the detection of antibody to the EHDV group, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of ova/embryos (1);]

(1) or [an agent identification test (6) carried out in approved laboratories on blood samples collected at commencement and conclusion of, and at least every seven days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of ova/embryos (1);]]

(1) either [II.2.7. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001;]

(1) or [II.2.7. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and are destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and the donor animals comply regarding scrapie with the guarantees provided for by the national scrapie control program referred to in that point and with the guarantees (7) requested by the Member State of destination;]

II.2.8. were collected/produced (1) after the date on which the embryo collection team was approved by the competent authority of the exporting country;

II.2.9. were processed and stored under approved conditions for at least 30 days immediately after their collection/production (1) and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.10. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in Box I.23;

(9) II.2.11. were conceived by artificial insemination/as a result of in vitro fertilisation (1) using semen coming from semen collection centres.

(1) either [II.2.11.1. approved in accordance with Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union, and the semen complies with the requirements of Directive 92/65/EEC.]

(1) or [II.2.11.1. approved in accordance with Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]’